Notably, caveolin-1 overexpression has been associated with radio-resistance in other tumours, like pancreatic cancer [111], suggesting the potential utility of strategies based on caveolin-1 inhibition to enhance radiotherapy efficacy. This evidence concerns the gene CAV1 and pancreatic neoplasm.